Read + Share
Amedeo Smart
Independent Medical Education
Naert T, Tulkens D, Van Nieuwenhuysen T, Przybyl J, et al. CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping. Proc Natl Acad Sci U S A 2021;118.PMID: 34789568
Email
LinkedIn
Facebook
Twitter
Privacy Policy